Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Conduit Pharmaceuticals Inc shares valued at $156,450 were sold by Nirland Ltd on Oct 03 ’24. At $0.10 per share, Nirland Ltd sold 1,500,000 shares. The insider’s holdings dropped to 8,400,000 shares worth approximately $0.59 million following the completion of this transaction.
Also, Nirland Ltd sold 1,368,991 shares, netting a total of over 140,458 in proceeds. Following the sale of shares at $0.10 each, the insider now holds 7,031,009 shares.
Before that, Nirland Ltd had sold 939,009 shares from its account. In a trade valued at $96,530, the 10% Owner traded Conduit Pharmaceuticals Inc shares for $0.10 each. Upon closing the transaction, the insider’s holdings decreased to 939,009 shares, worth approximately $0.43 million.
Analyzing CDT Stock Performance
During the last five days, there has been a drop of approximately -10.00%. Over the course of the year, Conduit Pharmaceuticals Inc shares have jumped approximately 7.58%. Shares of the company reached a 52-week high of $0.1832 on 01/10/25 and a 52-week low of $0.0665 on 01/06/25. A 50-day SMA is recorded $0.0879, while a 200-day SMA reached $0.9569. Nevertheless, trading volume fell to 19.33 million shares from 21.85 million shares the previous day.
Support And Resistance Levels for Conduit Pharmaceuticals Inc (CDT)
According to the 24-hour chart, there is a support level at 0.0687, which, if violated, would cause prices to drop to 0.0635. In the upper region, resistance lies at 0.0823. The next price resistance is at 0.0907. RSI (Relative Strength Index) is 46.43 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0032, which suggests the price will decrease in the coming days. Percent R is at 86.48%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
